Serum acid phosphatase level and biochemical recurrence following radical prostatectomy for men with clinically localized prostate cancer

Urology

Volumn 57, Issue 4, 2001, Pages 707-711

  Han, Misop ^a   Piantadosi, Steven ^a   Zahurak, Marianna L ^a   Sokoll, Lori J ^a   Chan, Daniel W ^a   Epstein, Jonathan I ^a   Walsh, Patrick C ^a   Partin, Alan W ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE; TUMOR MARKER;

ARTICLE; BLOOD; CANCER STAGING; DISEASE FREE SURVIVAL; ENZYMOLOGY; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MALE; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSTATE TUMOR; PROSTATECTOMY; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS;

ACID PHOSPHATASE; ACTUARIAL ANALYSIS; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 0035316503     PISSN: None     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/S0090-4295(00)01073-6     Document Type: Article

References (11)

1. C. Huggins C.V. Hodges Studies on prostatic cancer I the effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate Cancer Res 1 1941 293 297
2. A.B. Gutman E.B. Gutman An “acid” phosphatase occurring in the serum of patients with metastasizing carcinoma of the prostate gland J Clin Investigation 17 1938 473 478
3. F.C. Lowe S.J. Trauzzi Prostatic acid phosphatase in 1993. Its limited clinical utility Urol Clin North Am 20 1993 589 595
4. J.A. Whitesel R.E. Donohue J.H. Mani Acid phosphatase its influence on the management of carcinoma of the prostate J Urol 131 1984 70 72
5. T.A. Stamey N. Yang A.R. Hay Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate N Engl J Med 317 1987 909 916
6. A.L. Burnett D.W. Chan C.B. Brendler The value of serum enzymatic acid phosphatase in the staging of localized prostate cancer J Urol 148 1992 1832 1834
7. J.W. Moul R.R. Connelly B. Perahia The contemporary value of pretreatment prostatic acid phosphatase to predict pathological stage and recurrence in radical prostatectomy cases J Urol 159 1998 935 940
8. A.W. Partin M.W. Kattan E.N. Subong Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update JAMA 277 1997 1445 1451
9. A.W. Partin C.R. Pound J.Q. Clemens Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years Urol Clin North Am 20 1993 713 725
10. M.A. Hudson R.R. Bahnson W.J. Catalona Clinical use of prostate specific antigen in patients with prostate cancer J Urol 142 1989 1011 1017
11. J.E. Oesterling C.B. Brendler J.I. Epstein Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate J Urol 138 1987 92 98